Lung cancer is characterised by genetic modifications such as mutations inthe epidermal growth factor receptor (EGFR), fusion or rearrangement of the anaplastic lymphoma kinase (ALK), and various other abnormalities[8, 9]. This evidence concerns the gene EGFR and lung cancer.